A1ed0112-figure-01 (Montelukast Sodium Tablets 1)
Montelukast Sodium Tablet
Product Images NDC 65162-732
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 65162-732). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
A1ed0112-figure-02 (Montelukast Sodium Tablets 2)
This appears to be a graph showing the mean percent change from baseline for a treatment over a period of 15 weeks. The treatment options are a placebo and Montelukast Sodium. The graph shows the percentage change at various points in time within the 15-week period.*
30 Ct. (Montelukast Sodium Tablets 3)
This is a description of a medication with the NDC code 65162-732-09. Each tablet contains 10.4mg of Montelukast Sodium which is equivalent to 10 mg of Montelukast. The usual dosage is available in the package insert for prescribing information. It should be stored at temperatures between 20° to 25°C (68° to 77°F) and protected from light and moisture. This medication is for adults aged 15 years and older. It is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. The enclosed patient information leaflet should be dispensed by a pharmacist with the medication. There are 90 tablets included.*
Montelukast Sodium Tablets 4
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
